FDG PET/CT response in diffuse large B-cell lymphoma: Reader variability and association with clinical outcome

F-18-fluoro-2-deoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) is essential for monitoring response to treatment in patients with diffuse large B-cell lymphoma (DLBCL) and qualitative interpretation is commonly applied in clinical practice. We aimed to evaluate the intero...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Eun Ji, O, Joo Hyun, Yoon, Hyukjin, Jung, Seung Eun, Park, Gyeongsin, Choi, Byung Ock, Cho, Seok-Goo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
6800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5265944/
https://www.ncbi.nlm.nih.gov/pubmed/27684851
http://dx.doi.org/10.1097/MD.0000000000004983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5265944/
https://www.ncbi.nlm.nih.gov/pubmed/27684851
http://dx.doi.org/10.1097/MD.0000000000004983

Ejemplares similares